Non invasive diagnostic tools for visceral leishmaniasis: A comparison of the immunoserological tests DAT, rK26 and rK39;Herramientas no invasivas en Venezuela: Comparación entre las pruebas inmunoserológicas DAT, rK26 y rK39 en el diagnóstico de leishmaniasis visceral

Biomedica

Volumn 30, Issue 1, 2010, Pages 39-45

  Terán Ángel, Guillermo ^a   Rodríguez, Vestalia ^a   Silva, Rosilved ^a,b   Zerpa, Olga ^a   Schallig, Henk ^c   Ulrich, Marian ^a   Cabrera, Maira ^a  

^a INSTITUTO DE BIOMEDICINA   (Venezuela)

^b UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^c ROYAL TROPICAL INSTITUTE   (Netherlands)

Author keywords

Agglutination tests; Chromatography; Enzyme linked immunosorbent assay; Humans; Leishmania infantum; Leishmaniasis; Paper; Venezuela; Visceral diagnosis

Indexed keywords

LEISHMANIA INFANTUM;

EID: 77956108374     PISSN: 01204157     EISSN: None     Source Type: Journal    
DOI: 10.7705/biomedica.v30i1.151     Document Type: Article

References (36)

1. Kafetzis DA, Maltezou HC. Visceral leishmaniasis in pediatrics. Curr Opin Infect Dis. 2002;15:289-94.
2. Palatnik-de-Sousa CB, dos Santos WR, França-Silva JC, da Costa RT, Reis AB, Palatnik M, et al. Impact of canine control on the epidemiology of canine and human visceral Leishmaniasis in Brazil. Am J Trop Med Hyg. 2001;65:510-7.
3. Zerpa O, Ulrich M, Borges R, Rodríguez V, Centeno M, Negron E, et al. Epidemiological aspects of human and canine visceral leishmaniasis in Venezuela. Rev Panam Salud Pública. 2003;13:239-45.
4. WHO. Zoonoses and veterinary public health: Leishmaniasis [online]. Fecha de consulta: 15 de agosto de 2007]. Disponible en: http://www.who.int/zoonoses/diseases/leishmaniasis/en/.
5. OPS. Definiciones de caso: leishmaniasis visceral. Boletín Epidemiológico. 2002;23:14.
6. Sundar S, Rai M. Laboratory diagnosis of visceral leishmaniasis. Clin Diagn Lab Immunol. 2002;9:951-8.
7. Andrade CR, Nascimento AE, Moura PM, Andrade PP. Leishmania donovani donovani and Leishmania donovani chagasi as antigens in a direct agglutination assay for the diagnosis of kala-azar. Braz J Med Biol Res.1989;22:611-5.
8. ® for the diagnosis of human visceral leishmaniasis. Epidemiol Serv Saude. 2008;17:112-6.
9. Delgado O, Feliciangeli MD, Coraspe V, Silva S, Pérez A, Arias J. Value of a dipstick based on recombinant rk39 antigen for differential diagnosis of American visceral leishmaniasis from other sympatric endemic diseases in Venezuela. Parasite. 2001;8:355-7.
10. Garcez LM, Shaw JJ, Silveira FT. Direct agglutination tests in the serodiagnosis of visceral leishmaniasis in the state of Para. Rev Soc Bras Med Trop. 1996;29:165-80.
11. Pedras MJ, de Gouvêa Viana L, de Oliveira EJ, Rabello A. Comparative evaluation of direct agglutination test rK39 and soluble antigen ELISA and IFAT for the diagnosis of visceral leishmaniasis. Trans R Soc Trop Med Hyg. 2008;102:172-8.
12. Terán-Angel G, Schallig HD, Zerpa O, Rodríguez V, Ulrich M, Cabrera M. The direct agglutination test as an alternative method for the diagnosis of canine and human visceral leishmaniasis. Biomédica. 2007;27:447-53.
13. El Harith A, Kolk AH, Leeuwenburg J, Muigai R, Huigen E, Jelsma T, et al. Improvement of a direct agglutination test for field studies of visceral leishmaniasis. J Clin Microbiol.1988;26:1321-5.
14. Meredith SE, Kroon NC, Sondorp E, Seaman J, Goris MG, van Ingen CW, et al. Leish-KIT, a stable direct agglutination test based on freeze-dried antigen for serodiagnosis of visceral leishmaniasis. J Clin Microbiol.1995;33:1742-5.
15. Oskam L, Nieuwenhuijs JL, Hailu A. Evaluation of the direct agglutination test (DAT) using freeze-dried antigen for the detection of anti-Leishmania antibodies in stored sera from various patient groups in Ethiopia. Trans R Soc Trop Med Hyg.1999;93:275-7.
16. Valenstein PN. Evaluating diagnostic tests with imperfect standards. Am J Clin Pathol.1990;93:252-8.
17. Burns JM, Shreffler WG, Benson DR, Ghalib HW, Badaro R, Reed SG. Molecular characterization of a kinesin-related antigen of Leishmania chagasi that detects specific antibody in African and American visceral leishmaniasis. Proc Natl Acad Sci USA. 1993;90:775-9.
18. Salotra P, Sreenivas G, Beena KR, Mukherjee A, Ramesh V. Parasite detection in patients with post kala-azar dermal leishmaniasis in India: a comparison between molecular and immunological methods. J Clin Pathol. 2003;56:840-3.
19. Singh S, Kumari V, Singh N. Predicting kala-azar disease manifestations in asymptomatic patients with latent Leishmania donovani infection by detection of antibody against recombinant K39 antigen. Clin Diagn Lab Immunol. 2002;9:568-72.
20. Sreenivas G, Ansari NA, Singh R, Subba BV, Bhatheja R, Negi NS, et al. Diagnosis of visceral leishmaniasis: comparative potential of amastigote antigen, recombinant antigen and PCR. Br J Biomed Sci. 2002;59:218-22.
21. Ozensoy S, Ozbel Y, Turgay N, Alkan MZ, Gul K, Gilman-Sachs A, et al. Serodiagnosis and epidemiology of visceral leishmaniasis in Turkey. Am J Trop Med Hyg. 1998;59:363-9.
22. Qu JQ, Zhong L, Masoom-Yasinzai M, Abdur-Rab M, Aksu HS, Reed SG, et al. Serodiagnosis of Asian leishmaniasis with a recombinant antigen from the repetitive domain of a Leishmania kinesin. Trans R Soc Trop Med Hyg. 1994;8:543-5.
23. Zijlstra EE, Daifalla NS, Kager PA, Khalil EA, El-Hassan AM, Reed SG, et al. rK39 enzyme-linked immunosorbent assay for diagnosis of Leishmania donovani infection. Clin Diagn Lab Immunol. 1998;5:717-20.
24. Altman DG. Practical statistics for medical research. London: Chapman & Hall Press; 1991. p. 611.
25. Murray HW. Treatment of visceral leishmaniasis in 2004. Am J Trop Med Hyg. 2004;71:787-94.
26. Chulay JD, Bryceson AD. Quantitation of amastigotes of Leishmania donovani in smears of splenic aspirates from patients with visceral leishmaniasis. Am J Trop Med Hyg. 1983;32:475-9.
27. Hailu A, Musa AM, Royce C, Wasunna M. Visceral leishmaniasis: new health tools are needed. PLoS Med. 2005;2:e211.
28. Singh RK, Pandey HP, Sundar S. Visceral leishmaniasis (kala-azar): challenges ahead. Indian J Med Res. 2006;123:331-44.
29. Chappuis F, Rijal S, Soto A, Menten J, Boelaert M. A meta-analysis of the diagnostic performance of the direct agglutination test and rK39 Kalazar detect test for visceral leishmaniasis. BMJ. 2006;333:723.
30. Joshi AB, Singhasivanon P, Khusmith S, Fungladda W, Nandy A. Evaluation of direct agglutination test (DAT) as an immunodiagnostic tool for diagnosis of visceral leishmaniasis in Nepal. Southeast Asian J Trop Med Public Health.1999;30:583-5.
31. Carvalho SF, Lemos EM, Corey R, Dietze R. Performance of recombinant K39 antigen in the diagnosis of Brazilian visceral leishmaniasis. Am J Trop Med Hyg. 2003;68:321-4.
32. Sundar S, Reed SG, Singh VP, Kumar PC, Murray HW. Rapid accurate field diagnosis of Indian visceral leishmaniasis. Lancet. 1998;351:563-5.
33. Goswami RP, Bairagi B, Kundu PK. K39 strip test-easy, reliable and cost-effective field diagnosis for visceral leishmaniasis in India. J Assoc Physicians India. 2003;51:759-61.
34. Bhatia A, Daifalla NS, Jen S, Badaro R, Reed SG, Skeiky YA. Cloning, characterization and serological evaluation of K9 and K26: two related hydrophilic antigens of Leishmania chagasi. Mol Biochem Parasitol.1999;102:249-61.
35. Da Costa RT, Franca JC, Mayrink W, Nascimento E, Genaro O, Campos-Neto A. Standardization of a rapid immunochromatographic test with the recombinant antigens K39 and K26 for the diagnosis of canine visceral leishmaniasis. Trans R Soc Trop Med Hyg. 2003;97:678-82.
36. De Almeida L, Romero HD, Prata A, Costa RT, Nascimento E, Carvalho SF, et al. Immunologic tests in patients after clinical cure of visceral leishmaniasis. Am J Trop Med Hyg. 2006;75:739-43.